# Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring

> **NCT06005883** · — · COMPLETED · sponsor: **Keimyung University Dongsan Medical Center** · enrollment: 332 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Portal Vein Thrombosis
- Prognosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06005883
- **Lead sponsor:** Keimyung University Dongsan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-10
- **Primary completion:** 2021-08-10
- **Final completion:** 2022-04-10
- **Target enrollment:** 332 (ACTUAL)
- **Last updated:** 2023-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06005883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06005883, "Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06005883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*